IBS AG

  • WKN: 622840
  • ISIN: DE0006228406
  • Land: Deutschland

Nachricht vom 29.06.2012 | 15:48

IBS AG excellence, collaboration, manufacturing: Prof. Dr. Heiko Aurenz new Chairman of the IBS AG Supervisory Board, Volker Schwickert new CEO, André Bertram CFO


IBS AG excellence, collaboration, manufacturing / Key word(s): Change of Personnel

29.06.2012 / 15:48


IBS AG excellence, collaboration, manufacturing: Prof. Dr. Heiko Aurenz new Chairman of the IBS AG Supervisory Board, Volker Schwickert new CEO, André Bertram CFO

Hoehr-Grenzhausen, 29th June 2012 - The Supervisory Board of IBS AG, listed in the Prime Standard of the Frankfurt stock exchange (ISIN DE0006228406), appointed Prof. Dr. Heiko Aurenz as Chairman of the Supervisory Board in its meeting held on 28th June 2012. Prof. Dr. Aurenz has been a member of the IBS AG Supervisory Board since 2000.

As already announced, Dr. Klaus-Juergen Schroeder, former CEO and Company founder will leave the Company on 30th June 2012.

Volker Schwickert will assume his post as CEO of IBS AG from 1st July 2012. Mr. Schwickert has been a member of the IBS AG Board of Management since 1999.

The IBS AG Supervisory Board also appointed André Bertram to the Board of Management with effect from 1st July 2012. Mr. Bertram will be responsible for the area of finances.

'On behalf of the Supervisory Board, the Board of Management and the IBS employees I would like to thank the former CEO and Company founder, Dr. Klaus-Juergen Schroeder, for his sheer dedication in leading IBS AG to become one of the leading software and solutions providers in the field productivity management', said Chairman of the Supervisory Board, Prof. Dr. Aurenz. 'Mr. Schwickert taking on the role of CEO will enable the continuation of successful Board of Management activities. We are also delighted to welcome Mr. Bertram, an established financial expert, to the IBS Board of Management. His long-standing international experience and management expertise will complement the management of the Company.'

About IBS AG:

IBS AG is a leading supplier of cross-company standard software systems and consulting services for industrial quality, production, traceability and compliance management. In keeping with the corporate philosophy 'The Productivity Advantage', IBS AG's Best Practice solutions contribute to a sustainable boost in corporate productivity. IBS customers receive the support of a team of experienced consultants and specialists throughout each phase of the project and beyond. IBS AG, founded in 1982, today employs over 220 personnel in Europe, China and the USA.

The Company is listed in the Prime Standard of the German Stock Exchange in Frankfurt/Main (ISIN DE0006228406).

IBS AG software solutions amount to over 4,000 installations worldwide and can be found at companies such as Audi, Beam Global, BMW, BorgWarner, BOSCH, Caterpillar, Daimler, Electronic Networks, FCI Automotive, Kimberly Clark, KEIPER, Liebherr, Magna Automotive, KautexTextron, Parker Hannifin, Procter & Gamble, Rock Tenn, Porsche, Siemens, SMA Solar Technology, ThyssenKrupp and W.L. Gore.

Contact

Investor Relations IBS AG
c/o MLC Finance GmbH
Mussener Weg 7
95213 Muenchberg

Mr. Michael Lang
Tel.: + 49 (0) 9251 44088 30
Fax: + 49 (0) 9251 44088 31
e-mail: investorrelations@ibs-ag.de



End of Corporate News


29.06.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de



176049  29.06.2012

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

Original-Research: getgoods.de Anleihe (von GBC AG): stark überdurchschnittlich attraktiv getgoods.de Anleihe

24. Mai 2013